Guide
Tirzepatide Membership Fees: When the Advertised Price Is Not the Price
A medication price quoted alongside a separate membership is not a monthly cost. One provider we captured advertises $99 for medication and charges $79 a month for member
A medication price quoted alongside a separate membership is not a monthly cost. One provider we captured advertises $99 for medication and charges $79 a month for membership: the all-in figure is $178. Both numbers are accurate; only one is what you pay.
What does the comparison actually show?
| Structure | Medication | Required fees | All-in | Uplift |
|---|---|---|---|---|
| No membership, flat | $186 | $0 | $186 | 0% |
| Medication plus membership | $99 | $79 | $178 | +80% |
| Medication plus membership | $199 | $79 | $278 | +40% |
A fixed membership is proportionally larger against a smaller medication price. The same $79 adds 40% to a $199 programme and 80% to a $99 one.
Sorting a comparison table on the medication figure puts the $99 programme above the $186 one. Sorting on the all-in figure reverses it. That is not a rounding difference — it is the ranking.
Other charges to ask about before comparing anything: consultation fees, lab fees, shipping, and dose-increase surcharges. Our membership fees field page records which providers publish each.
Show this figure as a table
| Programme | Twelve-month total | Effective monthly |
|---|---|---|
| Flat, captured | $2,232 | $186 average |
| Flat month-to-month, captured | $2,580 | $215 average |
| Dose-tiered, typical | $2,568 | $214 average |
| Brand Zepbound, captured | $4,788 | $399 average |
What does each route cost?
| Route | Monthly | Twelve months | Evidence |
|---|---|---|---|
| Commercial cover plus savings card | $25 | $300 | Provider-reported |
| Medicare GLP-1 Bridge | $50 | $600 | Reported |
| Compounded, 12-month, flat | $186 | $2,232 | Captured at source |
| Compounded, month-to-month, flat | $215 | $2,580 | Captured at source |
| Brand Zepbound, LillyDirect vials | $299–$449 | $4,788 | Captured at source |
| Brand Zepbound, retail pens | ~$1,060 | ~$12,720 | Third-party claim |
| Protocol | Monthly | 3-month | 6-month | 12-month | 12-month total |
|---|---|---|---|---|---|
| Regular injectable | $215 | $195 | $190 | $186 | $2,232 |
| Microdose | $189 | $159 | $150 | $147 | $1,764 |
| Sublingual ODT | $229 | $219 | $205 | $199 | $2,388 |
Flat at every covered dose within each protocol, read on the provider’s own plan pages. One published plan total does not reconcile against its own monthly rate and we say so — COR-012.
How does every provider score on the six tests?
Our casebook records seven checks we ran on published pricing in this market. Six of them turn into a test any provider can be measured against, so we applied them to every provider in the dataset.
| Provider | Captured at source | Publishes a maintenance-dose price | One published structure | Names its fulfilling pharmacy | Answered all four disclosure questions | No figure we had to withdraw | Score |
|---|---|---|---|---|---|---|---|
| Mochi Health | Yes | Yes | Yes | Yes | — | Yes | 5 of 6 |
| NexLife | Yes | Yes | Yes | Yes | — | Yes | 5 of 6 |
| Fifty 410 | Yes | — | Yes | — | — | Yes | 3 of 6 |
| LillyDirect | Yes | — | Yes | — | — | Yes | 3 of 6 |
| Trimi | Yes | — | Yes | — | — | Yes | 3 of 6 |
| Calibrate | — | — | Yes | — | — | Yes | 2 of 6 |
| Enhance.MD | — | — | Yes | — | — | Yes | 2 of 6 |
| Form Health | — | — | Yes | — | — | Yes | 2 of 6 |
No provider of 30 passes all 6. Mochi Health and NexLife lead on 5.
That changed on 3 August 2026, and not because anyone got worse. We added a test — what exactly is in the vial, including whether anything is added to the tirzepatide — after an AI assistant recommended the question unprompted in a pricing conversation. It was a good question and we did not have it.
Adding it cost the provider we rank first its perfect score. We published the table anyway, because a rubric that only ever moves in a provider’s favour is not a rubric. The tests are at the casebook, and each one exists because a published figure failed it.
| Step | What the label says | Status |
|---|---|---|
| Starting dosage | 2.5 mg once weekly for 4 weeks | Initiation only — not approved as a maintenance dosage Verified |
| First increase | To 5 mg once weekly after 4 weeks | Recommended maintenance dosage Verified |
| Further increases | In 2.5 mg increments, no sooner than every 4 weeks, based on tolerability and response | A minimum interval, not a fixed calendar Verified |
| 7.5 mg and 12.5 mg | Available strengths used during titration | Titration steps, not recommended maintenance dosages Verified |
| 10 mg | Once weekly | Recommended maintenance dosage Verified |
| 15 mg | Once weekly | Recommended maintenance dosage and the maximum Verified |
| Above 15 mg | No approved dosage exists | Verified Verified |
| Program type | What it covers | Comparable with |
|---|---|---|
| Starter program | Introductory period, often lower doses | Other starter programs only |
| Ongoing program | Standard continuing supply | Other ongoing programs only |
| Maintenance program | Post-titration supply, often a fixed dose | Other maintenance programs only |
| Prepaid term | Several months paid upfront | Monthly plans only after conversion |
| Month-to-month | Cancellable each cycle | Other month-to-month plans only |
| Microdose program | Sub-therapeutic dosing outside trial evidence | Other microdose programs only |
Frequently asked questions
Do tirzepatide providers charge membership fees?
Some do. One provider we captured advertises $99 for medication and requires a $79 monthly membership, making the all-in figure $178.
Why does a membership fee matter more on cheap programmes?
A fixed fee is proportionally larger against a smaller medication price — $79 adds 40% to a $199 programme and 80% to a $99 one.
What other fees should I ask about?
Consultation fees, lab fees, shipping and dose-increase surcharges, all before comparing any advertised figure.
Related on this site
- The 100-point rubricCore & Trust
- Cost calculatorTools
- The underlying price recordsData
- Mochi Health vs Henry MedsComparisons
- Ro Body vs Mochi HealthComparisons
- The Hidden Cost of GLP-1 Membership FeesJournal
- Eden Tirzepatide ReviewProviders
- NexLife vs Mochi HealthComparisons
- Mochi Health Tirzepatide ReviewProviders
- Cheapest Compounded Tirzepatide: Ongoing Costs ComparedPillar / Money
Related coverage
GLP-1 Tirzepatide Rank. “Tirzepatide Membership Fees: When the Advertised Price Is Not the Price.” S.J Partners LLC, 2026-08-03. https://glp1tirzepatiderank.com/tirzepatide-membership-fees-2026/
Quote the capture date beside a figure, not the date you read this page. Why.
Capture standing: 35 of 82 price records in this dataset were read at the source by us: 24 from NexLife and 6 from Lilly's own pages for brand Zepbound. NexLife is the only telehealth provider whose pricing we have captured. Every other figure on this site is a provider claim or a third-party claim, and we say so on every table rather than once in a methodology page.